Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,981,000 | 8,050,000 | 7,356,000 | 11,103,000 | 7,425,000 |
| Marketable Securities | N/A | N/A | N/A | N/A | 7,000 |
| Receivables | 8,235,000 | 6,803,000 | 8,422,000 | 7,577,000 | 8,182,000 |
| Inventories | 6,402,000 | 5,554,000 | 6,128,000 | 6,056,000 | 5,846,000 |
| Other current assets | 5,291,000 | 7,357,000 | 4,671,000 | 4,607,000 | 4,714,000 |
| TOTAL | $26,909,000 | $27,764,000 | $26,577,000 | $29,343,000 | $26,174,000 |
| Non-Current Assets | |||||
| PPE Net | 18,295,000 | 17,000,000 | 16,919,000 | 15,789,000 | 15,269,000 |
| Investments And Advances | 544,000 | 785,000 | 1,372,000 | 1,251,000 | 555,000 |
| Intangibles | 34,613,000 | 32,983,000 | 36,925,000 | 36,633,000 | 35,863,000 |
| Other Non-Current Assets | 10,486,000 | 13,056,000 | 8,007,000 | 7,599,000 | 7,052,000 |
| TOTAL | $63,938,000 | $63,824,000 | $63,223,000 | $61,272,000 | $58,739,000 |
| Total Assets | $90,847,000 | $91,588,000 | $89,800,000 | $90,615,000 | $84,913,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,034,000 | 4,327,000 | 3,744,000 | 3,448,000 | 3,572,000 |
| Accrued Expenses | 11,911,000 | 12,212,000 | 11,690,000 | 11,182,000 | 10,932,000 |
| TOTAL | $26,361,000 | $27,327,000 | $20,405,000 | $22,178,000 | $23,483,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,002,000 | 25,360,000 | 26,321,000 | 26,156,000 | 21,637,000 |
| Other Non-Current Liabilities | 12,671,000 | 12,494,000 | 12,025,000 | 12,442,000 | 11,550,000 |
| TOTAL | $37,447,000 | $38,857,000 | $40,125,000 | $40,693,000 | $35,130,000 |
| Total Liabilities | $63,808,000 | $66,184,000 | $60,530,000 | $62,871,000 | $58,613,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,532,058 | 2,530,316 | 2,530,034 | 2,529,241 | 2,524,101 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 48,888,000 | 47,362,000 | 51,107,000 | 49,724,000 | 48,272,000 |
| Other shareholders' equity | -6,528,000 | -6,547,000 | -6,299,000 | -6,291,000 | -6,296,000 |
| TOTAL | $27,039,000 | $25,404,000 | $29,270,000 | $27,744,000 | $26,300,000 |
| Total Liabilities And Equity | $90,847,000 | $91,588,000 | $89,800,000 | $90,615,000 | $84,913,000 |